VEGFB and heart disorder: Therefore, it would be worth investigating VEGF-B's mechanisms of action further in dopaminergic neurons in the future to ultimately develop a VEGF-B targeted therapy that results in improving mitochondrial dysfunction in the context of cardiac disease and neurodegenerative disorders, including Parkinson's disease.